High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study (Q34996058)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study
scientific article

    Statements

    High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study (English)
    Monique Terwijn
    Wim L J van Putten
    Angèle Kelder
    Rik A Brooimans
    Thomas Pabst
    Nancy Boeckx
    Georgine E de Greef
    Peter J M Valk
    Frank W M B Preijers
    Peter C Huijgens
    Angelika M Dräger
    Urs Schanz
    Mojca Jongen-Lavrecic
    Bart J Biemond
    Michel van Gelder
    Pierre Wijermans
    Carlos Graux
    Mario Bargetzi
    Marie-Cecile Legdeur
    Jurgen Kuball
    Okke de Weerdt
    Leo F Verdonck
    Jan W Gratama
    Yvonne J M Oussoren
    Willemijn J Scholten
    Jennita Slomp
    Alexander N Snel
    Marie-Christiane Vekemans
    Gert J Ossenkoppele
    Gerrit J Schuurhuis
    23 September 2013
    3889-3897

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit